FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称BALSTILIMAB
异名/同义词A FULLY HUMAN IGG4 MONOCLONAL ANTAGONIST ANTIBODY DIRECTED AGAINST PROGRAMME D CELL DEATH PROTEIN 1 (PD-1) WITH POTENTIAL IMMUNE CHECKPOINT INHIBITORY AND ANTINEOPLASTIC ACTIVITIES
BALSTILIMAB
BALSTILIMAB [INN]
BALSTILIMAB [USAN]
BALSTILIMAB [WHO-DD]
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL AGEN2034 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AGEN2034 .KAPPA.-CHAIN, DIMER
AGEN2034
AGEN-2034
ANTI-PD1 MONOCLONAL ANTIBODY AGEN2034
CAS登记号2148321-77-9
物质唯一标识(Unique Ingredient Identifier)1Q2QT5M7EO
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System